仟源医药
(300254)
| 流通市值：22.73亿 | | | 总市值：25.94亿 |
| 流通股本：2.24亿 | | | 总股本：2.56亿 |
| 报告期 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 611,473,385.33 | 372,995,932.54 | 181,736,278.48 | 846,606,161.05 |
| 营业收入 | 611,473,385.33 | 372,995,932.54 | 181,736,278.48 | 846,606,161.05 |
| 二、营业总成本 | 552,167,468.27 | 353,806,273.79 | 173,536,336.36 | 792,256,406.11 |
| 营业成本 | 197,366,071.05 | 116,232,891.81 | 55,412,915.77 | 280,157,407.4 |
| 税金及附加 | 7,952,681.02 | 4,802,773.9 | 2,337,838.82 | 11,363,900.38 |
| 销售费用 | 194,954,237.54 | 129,873,094.8 | 69,071,111.47 | 302,495,118.14 |
| 管理费用 | 97,207,255.2 | 63,346,121.01 | 27,967,449.67 | 125,912,367.67 |
| 研发费用 | 37,164,425.08 | 27,725,300.37 | 12,891,525.28 | 56,533,374.23 |
| 财务费用 | 17,522,798.38 | 11,826,091.9 | 5,855,495.35 | 15,794,238.29 |
| 其中:利息费用 | 17,626,899.56 | 11,923,412.63 | 5,945,558.65 | 16,976,345.71 |
| 其中:利息收入 | 206,977.16 | 177,263.12 | 115,875.22 | 1,316,030 |
| 三、其他经营收益 | | | | |
| 加:投资收益 | 1,469,358.04 | 113,156.56 | 27,498.3 | 4,544,279.82 |
| 资产处置收益 | 7,943,493.79 | 7,895,012.66 | 7,881,410.52 | 7,507,360.71 |
| 资产减值损失(新) | 1,246,857.59 | 911,697.76 | 43,124.34 | -7,318,590.89 |
| 信用减值损失(新) | -2,545,129.87 | 510,134.82 | -80,477.88 | -5,818,941.95 |
| 其他收益 | 3,433,376.27 | 2,349,598.39 | 1,315,409.03 | 11,730,203.72 |
| 四、营业利润 | 70,853,872.88 | 30,969,258.94 | 17,386,906.43 | 64,994,066.35 |
| 加:营业外收入 | 12,238,913.39 | 9,024,543.49 | 6,099,294.69 | 22,206,003.55 |
| 减:营业外支出 | 5,723,452.46 | 4,430,200.21 | 1,235,939.12 | 6,557,442.19 |
| 五、利润总额 | 77,369,333.81 | 35,563,602.22 | 22,250,262 | 80,642,627.71 |
| 减:所得税费用 | 28,898,536.63 | 19,230,101.3 | 3,054,506.51 | 5,883,079.45 |
| 六、净利润 | 48,470,797.18 | 16,333,500.92 | 19,195,755.49 | 74,759,548.26 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 48,470,797.18 | 16,333,500.92 | 19,195,755.49 | 74,759,548.26 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 22,327,426.51 | 380,868.67 | 10,390,380.78 | 42,190,119.18 |
| 少数股东损益 | 26,143,370.67 | 15,952,632.25 | 8,805,374.71 | 32,569,429.08 |
| 扣除非经常损益后的净利润 | 17,526,985.32 | -5,011,716.56 | 2,790,407.8 | 25,228,696.32 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.09 | 0 | 0.04 | 0.17 |
| (二)稀释每股收益 | 0.09 | 0 | 0.04 | 0.17 |
| 九、综合收益总额 | 48,470,797.18 | 16,333,500.92 | 19,195,755.49 | 74,759,548.26 |
| 归属于母公司股东的综合收益总额 | 22,327,426.51 | 380,868.67 | 10,390,380.78 | 42,190,119.18 |
| 归属于少数股东的综合收益总额 | 26,143,370.67 | 15,952,632.25 | 8,805,374.71 | 32,569,429.08 |
| 公告日期 | 2025-10-30 | 2025-08-26 | 2025-04-19 | 2025-04-15 |
| 审计意见(境内) | | | | 标准无保留意见 |